Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Our Interventional Pulmonology Program offers advanced, minimally invasive diagnosis and treatment options for thoracic abnormalities and pulmonary disease. As part of the Chest Clinic, we provide care for lung cancer, airway disease, and pleural effusions, and advanced treatments for benign lung diseases like emphysema and asthma.
Care and Treatment
Evaluating Detection, Diagnosis, and Treatment Options
Clinical research underway in the Interventional Pulmonology Program includes studies on early lung cancer detection, biomarkers for lung cancer, and advanced non-invasive imaging.
Clinical trials also include bronchoscopic lung volume reduction for appropriate emphysema patients, advanced real-time imaging to assist thoracic surgeons and bronchoscopists with sampling of tissues and potential future therapies, and sampling of patients with chronic airway diseases like asthma for molecular biologic investigations.
The SILK (Stanford Innovation in Lung Knowledge) Program supports doctors and and doctors-in-training to advance interventional pulmonology education, research, and technology, and train future leaders.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referring Physicians.
HOW TO REFER
Fax a referral form with supporting documentation to 650-320-9443.
Track your patients' progress and communicate with Stanford providers securely online.